Mind Medicine MindMed (MNMD)
(Delayed Data from NSDQ)
$7.32 USD
-0.16 (-2.14%)
Updated Jun 18, 2024 04:00 PM ET
After-Market: $7.32 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Mind Medicine (MindMed) Inc. [MNMD]
Reports for Purchase
Showing records 61 - 73 ( 73 total )
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Positive Phase 2 Top-Line Results for LSD in Anxiety Provides Positive Read Through to MM-120; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage of Mind Medicine (MindMed) with a Buy rating
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
4Q21 Results; Broad Mental Healthcare Pipeline on Track With Multiple Study Starts and Data Updates Expected Near-Term
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Potential Blockbuster R(-)-MDMA Program Advancing to Phase 1 in 2022
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
2Q21 Results; Lead Programs Focused on 18-MC and LSD Progressing; Momentum Building Ahead of Key Data Updates
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
Company: Mind Medicine (MindMed) Inc.
Industry: Medical - Biomedical and Genetics
The Doors of Perception: Psychedelic Renaissance Could End With Multiple Breakthrough Therapies in Psychiatry and Beyond
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P